Navigation Links
HelpMeSee & Cornerstone Assistance Showcase MSICS In Texas
Date:8/8/2014

FORT WORTH, Texas, Aug. 8, 2014 /PRNewswire-USNewswire/ -- HelpMeSee – a global campaign to eliminate cataract blindness – and the Cornerstone Assistance Network – a nonprofit providing direct services to individuals and families struggling with poverty in, and around, Tarrant County, Texas – have teamed up to showcase a safe, low cost approach to curing cataract blindness through Manual Small Incision Cataract Surgery (MSICS) and to run a side-by-side surgical procedure comparison with the latest proof-of-concept HelpMeSee MSICS Simulator.

During the live surgeries, a team of engineers from HelpMeSee simulation technology partners, Moog Industrial Group, a division of Moog Inc. (NYSE: MOG.A and MOG.B) – jointly selected to design and manufacture the simulator along with SenseGraphics and InSimo – will be on hand with the latest version of the MSICS Simulator. The main purpose of this comparative analysis is focused on fine-tuning the simulation system to ensure maximum realism of the completed training MSICS simulator.  

Conducted by HelpMeSee's Chief Medical Officer, and Texas ophthalmologist, Dr. Glenn Strauss, in collaboration with the Cornerstone Charitable Clinic, seven local area citizens suffering from curable blindness due to cataracts will receive the cataract surgical procedure through the Cornerstone Assistance Network.

"We are proud to have Dr. Strauss and the HelpMeSee team at the Cornerstone Facility to provide sight-restoring cataract surgery to our local residents in need," said Lorene McCoy, director of health services, Cornerstone Charitable Clinic. "Cornerstone has a long history of helping those in need and we are proud to learn of HelpMeSee's global efforts to address cataract blindness."

HelpMeSee's organizational approach underlines the acknowledgement that MSICS is the best available technique to successfully address the nearly 22 million people suffering from cataract blindness globally.

"This is a historical step in the MSICS simulator development," said Dr. Glenn Strauss, chief medical officer, HelpMeSee. "By viewing live MSICS procedures, our engineering partners are able to accurately compare the performance of this leading edge simulator to the actual surgery. Realism not achieved in medical simulation previously."

Dr. Strauss added that the HelpMeSee MSICS Simulator – once completed, tested and validated by leading US and European University Ophthalmology programs – will be used to safely and efficiently train thousands of specialists in developing nations to perform MSICS for their own people. 

According to the American Academy of Ophthalmology, MSICS has been shown to give results comparable to the popular phacoemulsification procedure in terms of safety and quality of visual outcome. Although it's a relatively underutilized technique, MSICS is gaining popularity in many countries by virtue of its ability to manage both common, and difficult, cataracts very safely and with strong outcomes.

"A distinct advantage of MSICS over Phacoemulsification is that it can be used more safely to remove advanced cataracts in the developing world," said Dr. Strauss. "Patients with no access to care gradually develop cataracts that are much more advanced than those who can have an operation before the cataracts advances to blindness.  This procedure is a perfect solution because the cost to provide it is much lower, while producing the same quality expected in modern cataract surgery."

Dr. Strauss explains that although phacoemulsification cataract surgery is considered the gold standard for cataract removal, it requires expensive machinery and an uninterrupted power source – both are challenges in the developing world where virtually all suffering from cataract blindness reside. Furthermore, the overall cost and maintenance of machinery and supplies for this procedure makes it cost-prohibitive for regions with inadequate infrastructure.

Throughout the world, untreated cataracts are the leading cause of blindness, making up 51% of all cases. Approximately 22 million people are bilaterally blind due to cataracts, and an estimated 167 million suffer from cataract visual impairment. The unfortunate truth is that the vast majority of people afflicted by the debilitating condition live in developing countries, where their livelihoods and their families' wellbeing depends greatly on their eyesight. These populations lack access to high-quality medical services – preventing them from receiving the surgeries that could restore their vision.

About HelpMeSee
HelpMeSee (www.HelpMeSee.org) is a global campaign to eliminate cataract blindness endemic in developing countries. The HelpMeSee mission is make the sight-restoring surgery available to millions of poor through financial support and the training of thousands of highly skilled specialist cataract surgeons recruited from within their communities. HelpMeSee has designed and is now producing a virtual reality surgical simulator and training program to be implemented worldwide, adapted from extensive experience in simulator based aviation training.

About Cornerstone Assistance Network
Since its inception in 1992, Cornerstone (www.canetwork.org) has been committed to helping churches, organizations, and volunteers become involved in the lives of the people in their community. The Cornerstone Assistance Network Cataract Clinic is the nation's first charitable cataract facility providing treatment for the uninsured and economically disadvantaged. The Cataract Clinic is operated by Cornerstone Charitable Clinic, a Division of Cornerstone Assistance Network and gives hope and provides solutions for patients with loss of vision and no ability to pay for sight-restoring procedures.

Contact:
Perry Athanason
perry@helpmesee.org
917-319-2126

Logo - http://photos.prnewswire.com/prnh/20130403/DC88441LOGO


'/>"/>
SOURCE HelpMeSee
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
3. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
11. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , Feb. 17, 2017   FormFast , ... announced a new partnership with Engage , one ... United States . FormFast will serve as the ... Engage,s implementations with MEDITECH .  ... essential functionality to complement and enhance the electronic health ...
(Date:2/17/2017)...  BioDigital, Inc., creators of the BioDigital Human ... body mapping technology with eClinicalWorks, a privately held ... be used to capture and present dermatology exam ... body. BioDigital pilots show using a body to ... the precision of clinical annotations compared to standard ...
(Date:2/17/2017)... YORK , Feb. 17, 2017  Noble Capital ... on ESSA Pharma Inc. (Nasdaq: EPIX ). ... Research, Kumar Raja , PhD. ESSA ... for castration resistant prostate cancer (CRPC). Its lead compound ... blocks the amino-terminal domain of the androgen receptor, thereby ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... ... self-service technology that runs on the Posiflex XT-series of touch screen terminals. Both ... HIMSS17 in Orlando, Florida. The terminal provider Posiflex is helping to bridge ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... welcomes you to stop by for a visit this week at HIMSS 2017 ... and executives from around the globe. Sensogram will be featured in the conference’s ...
(Date:2/20/2017)... Houston, TX (PRWEB) , ... February 20, 2017 ... ... he is now offering a full range of emergency dental care at his ... teeth and gums. When patients experience dental emergencies, they are at risk for ...
(Date:2/20/2017)... Orlando, FL (PRWEB) , ... February 20, 2017 ... ... company for eye care providers and health plan partners, announced during the 2017 ... the organization’s success enhancing care coordination for diabetic patients and integrating eye ...
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... Braun Industries ... JEMS Conference & Exposition, the event will take place February 23-25, 2017 at the ... will be in Booth #909 with three new ambulances on display. ...
Breaking Medicine News(10 mins):